Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST
SONN Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 2 | 5 | 7 | 35 | 35 | - | |
| Market Cap Growth | -83.93% | -30.09% | -79.64% | 0.50% | - | - | |
| Enterprise Value | -2 | -2 | 2 | 29 | 32 | - | |
| Last Close Price | 2.92 | 22.92 | 258.72 | 1493.18 | 6332.48 | - | |
| PS Ratio | 151.13 | 33.93 | 20.50 | 72.86 | - | - | |
| PB Ratio | 0.73 | -22.19 | -2.83 | 1.58 | 11.61 | - | |
| P/TBV Ratio | 1.11 | - | - | 1.58 | 11.61 | - | |
| EV/Sales Ratio | - | - | 6.35 | 60.68 | - | - | |
| Debt / Equity Ratio | 0.06 | -0.90 | -0.10 | 0.01 | 0.12 | -0.08 | |
| Asset Turnover | 0.01 | 0.03 | 0.02 | 0.03 | - | - | |
| Quick Ratio | 1.31 | 0.55 | 0.46 | 4.12 | 1.56 | 0.01 | |
| Current Ratio | 1.65 | 0.86 | 0.66 | 4.30 | 1.62 | 0.01 | |
| Return on Equity (ROE) | -264.57% | - | -301.42% | -197.66% | -27822.18% | - | |
| Return on Assets (ROA) | -96.93% | -208.63% | -106.50% | -84.78% | -270.89% | -13028.92% | |
| Return on Capital (ROIC) | -239.49% | - | -184.48% | -121.74% | -2921.10% | - | |
| Earnings Yield | -420.52% | -375.53% | -414.34% | -70.90% | -69.20% | - | |
| FCF Yield | -526.44% | -425.56% | -387.18% | -64.01% | -44.75% | - | |
| Buyback Yield / Dilution | -377.77% | -425.76% | - | - | - | - | |
| Total Shareholder Return | -377.77% | -425.76% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.